...the fact that the downwards pricing spiral leads to supply situations in which the negotiation balance tips to monopoly pharma suppliers. #Pharmamarket #Pricing #Supply

...probably not yet a spaceship to new pharma horizons - but it's clearly taking off! #BigData #BigPharma #Pharmamarket

...and winning strategies translate relevant medical data into meaningful value propositions for payers' budgetary planning security. Contact us to learn more! #HTA #Pricing #Pharmamarket

...and so do the functions serving networks of care. Patients demand individual healthcare solutions and payers expect to pay for performance. #Patientcentricity #Pharmamarket #Organisationaldesign

...and so do organisations. Driver for organisational development are new stakeholders, new technologies and above all, a new MINDSET! New mindsets start with new experiences. The experiences that matter most to pharma is to actually be in touch with real patients and caregivers, policy-makers & payers and to understand their language and to comprehend their needs. All have a common goal: better health outcomes. All need to permanently re-define their role and the value that

...is about getting accepted as a member of networks of patient care. #Pharmamarket #Networkofcare #Patientcentricity #Customer

...for 80% of the world's population. The biggest pharma market of the world, the US, represents 40% of the world's pharma market...and 5% of the world's population and contributes the largest proportion of pharmaceutical R&D and innovation. #HTA #Pricing #Pharmamarket